The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Rethinking the Warburg Effect with Myc Micromanaging Glutamine Metabolism
Open accessAbstract
The MYC oncogene, which is frequently deregulated in human cancers, encodes a master transcription factor c-Myc (herein termed Myc) that integrates cell proliferation with metabolism through its regulation of thousands of genes including microRNAs (miRNA). In addition to its known function in regulating the cell cycle and glucose metabolism, recent studies document a role for Myc in stimulating glutamine catabolism, in part through the repression of miRNAs miR-23a and miR-23b. These observations suggest an additional level of complexity in tumor metabolism, which includes the commensal metabolic relationship between hypoxic and nonhypoxic regions of tumors as well as the surrounding stroma. Thus, a reevaluation of cancer metabolism considering glutamine catabolism with a better understanding of the tumor histological complexity is needed before cancer metabolism can be effectively targeted in therapy. Cancer Res; 70(3); 859–62
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, cancer cells driven by oncogenic MYC, K-Ras, and PIK3CA require glutamine for their survival and display extensive anabolic utilization of glutamine29,174,175”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [174]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
Tumor cell metabolism: cancer's Achilles' heel
Kroemer, G., & Pouyssegur, J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.005 · Cited by 2,337
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Self-citationWise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice
Sonveaux, P., Végran, F., Schroeder, T., Wergin, M., Verrax, J., Rabbani, Z. N., Saedeleer, C. J. D., Kennedy, K. M., Diepart, C., Jordan, B. F., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36843 · Cited by 1,635
The impact of O2 availability on human cancer
Bertout, J. A., Patel, S. A., & Simon, M. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2540 · Cited by 1,365
Cancer's Molecular Sweet Tooth and the Warburg Effect
Kim, J., & Dang, C. V. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1501 · Cited by 1,233
Self-citationc-Myc transactivation of LDH-A : Implications for tumor metabolism and growth
Shim, H., Dolde, C., Lewis, B. C., Wu, C.-S., Dang, G., Jungmann, R. A., Dalla-Favera, R., & Dang, C. V. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6658 · Cited by 1,092
Self-citationFlier, J. S., Mueckler, M., Usher, P., & Lodish, H. F. (1987) · Science · doi:10.1126/science.3103217 · Cited by 783
Cited by
Sorted by citations
Items 101–200 of 381
Lecarpentier, Y., CLAES, V. A., Vallée, A., & Hébert, J. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0144-7 · Cited by 76
Sirtuins in Cancer: a Balancing Act between Genome Stability and Metabolism
Jeong, S. M., & Haigis, M. C. (2015) · Molecules and Cells · doi:10.14348/molcells.2015.0167 · Cited by 74
1H NMR Metabolomics Analysis of Glioblastoma Subtypes
Čuperlović‐Culf, M., Ferguson, D., Culf, A. S., Morin, P., & Touaibia, M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.337196 · Cited by 73
The impact of MYC expression in lymphoma biology: Beyond Burkitt lymphoma
Smith, S. M., Anastasi, J., Cohen, K. S., & Godley, L. A. (2010) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2010.08.002 · Cited by 75
Wasylishen, A. R., & Penn, L. Z. (2010) · Genes & Cancer · doi:10.1177/1947601910378024 · Cited by 77
Ye, J., Huang, Q., Xu, J., Huang, J., Wang, J., Zhong, W., Chen, W., Lin, X., & Lin, X. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2605-9 · Cited by 71
Autophagy in stem and progenitor cells
Rodolfo, C., Bartolomeo, S. D., & Cecconi, F. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2071-3 · Cited by 72
Ding, M., Li, F., Wang, B., Chi, G., & Liu, H. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28377 · Cited by 69
Role of tyrosine phosphorylation in modulating cancer cell metabolism
Taddei, M. L., Pardella, E., Pranzini, E., Raugei, G., & Paoli, P. D. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188442 · Cited by 70
AMPK regulates metabolism and survival in response to ionizing radiation
Zannella, V. E., Cojocari, D., Hilgendorf, S., Vellanki, R. N., Chung, S., Wouters, B. G., & Koritzinsky, M. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.05.049 · Cited by 68
Carbon Source Metabolism and Its Regulation in Cancer Cells
Yin, C., Qie, S., & Sang, N. (2012) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v22.i1.20 · Cited by 67
Mass spectrometry‐based strategies for single‐cell metabolomics
Hu, R., Li, Y., Yang, Y., & Liu, M. (2021) · Mass Spectrometry Reviews · doi:10.1002/mas.21704 · Cited by 65
Acidosis Promotes Bcl-2 Family-mediated Evasion of Apoptosis
Ryder, C. B., McColl, K. S., Zhong, F., & Distelhorst, C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.384685 · Cited by 65
Wnt meets Warburg: another piece in the puzzle?
Thompson, C. B. (2014) · The EMBO Journal · doi:10.15252/embj.201488785 · Cited by 65
Linking Cancer Metabolism to DNA Repair and Accelerated Senescence
Efimova, E. V., Takahashi, S., Shamsi, N. A., Wu, D., Labay, E., Ulanovskaya, O. A., Weichselbaum, R. R., Kozmin, S. A., & Kron, S. J. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0263 · Cited by 65
Ammonia: A Diffusible Factor Released by Proliferating Cells That Induces Autophagy
Mariño, G., & Kroemer, G. (2010) · Science Signaling · doi:10.1126/scisignal.3124pe19 · Cited by 66
Crosstalk between Hypoxia and Extracellular Matrix in the Tumor Microenvironment in Breast Cancer
Dekker, Y., Dévédec, S. E. L., Danen, E. H. J., & Liu, Q. (2022) · Genes · doi:10.3390/genes13091585 · Cited by 66
EBV-miR-BART1 is involved in regulating metabolism-associated genes in nasopharyngeal carcinoma
Ye, Y., Zhou, Y., Zhang, L., Chen, Y., Lyu, X., Cai, L., Lu, Y., Deng, Y., Wang, J., Yao, K., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.05.008 · Cited by 64
Hsa-let-7a functions as a tumor suppressor in renal cell carcinoma cell lines by targeting c-myc
Liu, Y., Yin, B., Zhang, C., Zhou, L., & Fan, J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.11.119 · Cited by 63
Willers, I. M., & Cuezva, J. M. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.10.016 · Cited by 65
CD44-SLC1A2 Gene Fusions in Gastric Cancer
Tao, J., Deng, N., Ramnarayanan, K., Huang, B., Oh, H. K., Leong, S. H., Lim, S. S., Tan, I. B., Ooi, C.-H., Wu, J., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001423 · Cited by 63
Schulte, M. I., Khodadadi, A. B., Cuthbertson, M. L., Smith, J. A., & Manning, H. C. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.12.031 · Cited by 62
Sato, M., Kawana, K., Adachi, K., Fujimoto, A., Yoshida, M., Nakamura, H., Nishida, H., Inoue, T., Taguchi, A., Takahashi, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8947 · Cited by 63
On metabolic reprogramming and tumor biology: A comprehensive survey of metabolism in breast cancer
Penkert, J., Ripperger, T., Schieck, M., Schlegelberger, B., Steinemann, D., & Illig, T. (2016) · Oncotarget · doi:10.18632/oncotarget.11759 · Cited by 64
Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2018) · Neuroscience Bulletin · doi:10.1007/s12264-018-0219-5 · Cited by 62
Kandasamy, P., Zlobec, I., Nydegger, D. T., Pujol‐Giménez, J., Bhardwaj, R., Shirasawa, S., Tsunoda, T., & Hediger, M. A. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12999 · Cited by 60
MicroRNAs: tiny targets for engineering CHO cell phenotypes?
Barron, N., Sanchez, N., Kelly, P. S., & CLYNES, M. M. (2010) · Biotechnology Letters · doi:10.1007/s10529-010-0415-5 · Cited by 65
Sikder, M. O. F., Yang, S., Ganapathy, V., & Bhutia, Y. D. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0164-7 · Cited by 61
Frederick, M. J., Skinner, H. D., Kazi, S. A., Sikora, A. G., & Sandulache, V. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-63448-z · Cited by 58
Energy metabolism in cancer stem cells
Zhu, X., Chen, H., Gao, C., Zhang, X., Jiang, J., Zhang, Y., Fang, J., Zhao, F., & Chen, Z. (2020) · World Journal of Stem Cells · doi:10.4252/wjsc.v12.i6.448 · Cited by 62
Targeting MYC-Regulated miRNAs to Combat Cancer
Frenzel, A., Lovén, J., & Arsenian‐Henriksson, M. (2010) · Genes & Cancer · doi:10.1177/1947601910377488 · Cited by 60
Wang, H., Lu, J. L., Edmunds, L. R., Kulkarni, S., Dolezal, J. M., Tao, J., Ranganathan, S., Jackson, L. E., Fromherz, M., Beer–Stolz, D., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.754218 · Cited by 58
Gonsalves, W. I., Ramakrishnan, V., Hitosugi, T., Ghosh, T., Jevremovic, D., Dutta, T., Sakrikar, D., Petterson, X.-M., Wellik, L., Kumar, S. K., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.94543 · Cited by 57
Amano, Y., Mandai, M., Yamaguchi, K. D., Matsumura, N., Kharma, B., Baba, T., Abiko, K., Hamanishi, J., Yoshioka, Y., & Konishi, I. (2015) · Oncotarget · doi:10.18632/oncotarget.4692 · Cited by 58
Lund, T., Callaghan, M. F., Williams, P., Turmaine, M., Bachmann, C., Rademacher, T., Roitt, I. M., & Bayford, R. H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.018 · Cited by 56
Fisher, K. W., Das, B., Kortum, R. L., Chaika, O. V., & Lewis, R. E. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05255-11 · Cited by 60
de Oliveira, A. G., & Gomes‐Marcondes, M. C. C. (2016) · BMC Cancer · doi:10.1186/s12885-016-2424-9 · Cited by 58
RETRACTED: Myc is a prognostic biomarker and potential therapeutic target in osteosarcoma
Feng, W., Dean, D. C., Hornicek, F. J., Spentzos, D., Hoffman, R. M., Shi, H., & Duan, Z. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920922055 · Cited by 57
RetractedWu, H., Li, Z., Yang, P., Zhang, L., Fan, Y., & Li, Z. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.07.024 · Cited by 56
Role of diet in prostate cancer: the epigenetic link
Labbé, D. P., Zadra, G., Ebot, E. M., Mucci, L. A., Kantoff, P. W., Loda, M. F., & Brown, M. A. (2014) · Oncogene · doi:10.1038/onc.2014.422 · Cited by 56
Oncogenes and Tumor Suppressors Regulate Glutamine Metabolism in Cancer Cells
Kim, M., & Kim, H. (2013) · Journal of Cancer Prevention · doi:10.15430/jcp.2013.18.3.221 · Cited by 54
Morbelli, S. D., Alama, A., Ferrarazzo, G., Coco, S., Genova, C., Rijavec, E., Bongioanni, F., Biello, F., Bello, M. G. D., Barletta, G., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.193201 · Cited by 52
O-GlcNAcylation: key regulator of glycolytic pathways
Bacigalupa, Z. A., Bhadiadra, C., & Reginato, M. J. (2018) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-018-9742-3 · Cited by 52
The Heterogeneity of Liver Cancer Metabolism
Salazar, J., & Le, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-65768-0_9 · Cited by 57
Nair, V. S., Gevaert, O., Davidzon, G., Plevritis, S. K., & West, R. B. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.11.001 · Cited by 51
Beckham, T. H., Lü, P., Jones, E. E., Marrison, S. T., Lewis, C. S., Cheng, J., Ramshesh, V. K., Beeson, G. C., Beeson, C. C., Drake, R. R., et al. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.199216 · Cited by 51
MicroRNAs and the Warburg Effect: New Players in an Old Arena
Gao, P., Sun, L., He, X., Cao, Y., & Zhang, H. (2012) · Current Gene Therapy · doi:10.2174/156652312802083620 · Cited by 51
Bharadwaj, S., Singh, M. V., Kirtipal, N., & Kang, S. G. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.627842 · Cited by 50
Areca Nut Induces miR-23a and Inhibits Repair of DNA Double-Strand Breaks by Targeting FANCG
Tsai, Y., Lin, C., Chiang, S., Lee, C., Lee, K., & Ko, Y. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr182 · Cited by 50
Kelly, P. S., Breen, L., Gallagher, C., Kelly, S., Henry, M., Lao, N. T., Meleady, P., O'Gorman, D., Clynes, M., & Barron, N. (2015) · Biotechnology Journal · doi:10.1002/biot.201500101 · Cited by 49
MAD1 and its life as a MYC antagonist: An update
Lüscher, B. (2011) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2011.07.005 · Cited by 49
Mitochondrial metabolic reprogramming: An important player in liver cancer progression
Jin, T., Wang, C., Tian, Y., Dai, C., Zhu, Y., & Xu, F. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.11.029 · Cited by 49
Metabolic adaptations in cancer stem cells: A key to therapy resistance
Masoudi, M., Moti, D., Masoudi, R., Auwal, A., Hossain, M. M., Pronoy, T. U. H., Rashel, K. M., Gopalan, V., & Islam, F. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167164 · Cited by 48
Microtargeting cancer metabolism: opening new therapeutic windows based on lipid metabolism
de Cedrón, M. G., & de Molina, A. R. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r061812 · Cited by 49
IntLIM: integration using linear models of metabolomics and gene expression data
Siddiqui, J., Baskin, E., Liu, M., Cantemir-Stone, C. Z., Zhang, B., Bonneville, R., McElroy, J. P., Coombes, K. R., & Mathé, E. A. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2085-6 · Cited by 48
Qu, X., Sun, J., Zhang, Y., Li, ., Hu, J., Li, K., Gao, L., & Shen, L. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.08.069 · Cited by 47
Carbon Source and Myc Expression Influence the Antiproliferative Actions of Metformin
Javeshghani, S., Zakikhani, M., Austin, S., Bazile, M., Blouin, M., Topisirović, I., St‐Pierre, J., & Pollak, M. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2907 · Cited by 49
Cai, C., Ye, G.-D., Shen, D., Zhang, W., Chen, M.-L., Chen, X., Han, D., Mi, Y., Luo, Q., Cai, W., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0769-4 · Cited by 47
Zhang, Y., Zeng, S., Ma, J., Deng, G., Qu, Y., Guo, C., & Shen, H. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0387-y · Cited by 46
Cheng, T.-M., Chu, H., Lee, Y.-C., Wang, D., Chang, C., Chung, K.-L., Yen, H., Hsiao, C.-W., Pan, X.-Y., Kuo, T., et al. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.7b04961 · Cited by 46
Cui, F., Fan, R., Chen, Q., He, Y., Song, M. S., Shang, Z., Zhang, S., Zhu, W. Z., Cao, J., Guan, H., et al. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2422-2 · Cited by 46
Glutamine metabolism: from proliferating cells to cardiomyocytes
Shen, Y., Zhang, Y., Li, W., Chen, K., Xiang, M., & Ma, H. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154778 · Cited by 44
Metformin-induced metabolic reprogramming of chemoresistant ALDHbright breast cancer cells
Cioce, M., Valerio, M., Casadei, L., Pulito, C., Sacconi, A., Mori, F., Biagioni, F., Manetti, C., Muti, P. C., Strano, S., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1864 · Cited by 45
Ammonia Drives Dendritic Cells into Dysfunction
Luo, C., Shen, G., Liu, N., Gong, F., Wei, X., Yao, S., Liu, D., Teng, X., Ye, N., Zhang, N., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303218 · Cited by 45
Shan, M., Dai, D. L., Vudem, A., Varner, J. D., & Stroock, A. D. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006584 · Cited by 47
Metabolic reprogramming by tobacco-specific nitrosamines (TSNAs) in cancer
Sarlak, S., Lalou, C., Amoêdo, N. D., & Rossignol, R. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.09.001 · Cited by 50
Prolyl isomerase Pin1 in metabolic reprogramming of cancer cells
Nakatsu, Y., Yamamotoya, T., Ueda, K., Ono, H., Inoue, M.-K., Matsunaga, Y., Kushiyama, A., Sakoda, H., Fujishiro, M., Matsubara, A., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.10.043 · Cited by 43
MicroRNA‐195 controls MICU1 expression and tumor growth in ovarian cancer
Rao, G., Dwivedi, S. K. D., Zhang, Y., Dey, A., Shameer, K., Karthik, R., Srikantan, S., Hossen, M. N., Wren, J. D., Madesh, M., et al. (2020) · EMBO Reports · doi:10.15252/embr.201948483 · Cited by 44
Exercise tames the wild side of the Myc network: a hypothesis
Gohil, K., & Brooks, G. A. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00027.2012 · Cited by 42
Sharma, S. H., Thulasingam, S., Chellappan, D. R., Chinnaswamy, P., & Nagarajan, S. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.12.019 · Cited by 42
Metabolic PET Imaging in Oncology
Sai, K. K. S., Zachar, Z., Bingham, P. M., & Mintz, A. (2017) · American Journal of Roentgenology · doi:10.2214/ajr.17.18112 · Cited by 43
DNA Microarray and miRNA Analyses Reinforce the Classification of Follicular Thyroid Tumors
Jacques, C., Guillotin, D., Fontaine, J., Franc, B., Mirebeau‐Prunier, D., Fleury, A., Malthièry, Y., & Savagner, F. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4006 · Cited by 43
Friday, E., Oliver, R., Welbourne, T., & Turturro, F. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22360 · Cited by 42
Roles of the mitochondrial genetics in cancer metastasis: not to be ignored any longer
Beadnell, T. C., Scheid, A. D., Vivian, C. J., & Welch, D. R. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9772-7 · Cited by 42
Malik, A., Korol, A. B., Weber, M., Hankeln, T., Avivi, A., & Band, M. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-615 · Cited by 41
Li, Y., Li, X., Li, X., Zhong, Y., Ji, Y., Yu, D., Zhang, M., Wen, J., Zhang, H., Goscinski, M. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10782 · Cited by 43
RetractedSandulache, V. C., & Myers, J. N. (2011) · Head & Neck · doi:10.1002/hed.21664 · Cited by 38
Systems approach to characterize the metabolism of liver cancer stem cells expressing CD133
Hur, W., Ryu, J. Y., Kim, H. U., Hong, S. W., Lee, E. B., Lee, S. Y., & Yoon, S. K. (2017) · Scientific Reports · doi:10.1038/srep45557 · Cited by 39
14-3-3 σ: A potential biomolecule for cancer therapy
Huang, Y., Yang, M., & Huang, W. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.09.009 · Cited by 39
Zhang, L., Zhai, B.-Z., Wu, Y., & Wang, Y. (2023) · Drug Delivery · doi:10.1080/10717544.2022.2144541 · Cited by 39
Xue, M., Wei, W., Su, Y., Johnson, D., & Heath, J. R. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.5b12187 · Cited by 37
Normoxic accumulation of HIF1α is associated with glutaminolysis
Kappler, M., Pabst, U., Rot, S., Taubert, H. W., Wichmann, H., Schubert, J., Bache, M., Weinholdt, C., Immel, U., Große, I., et al. (2016) · Clinical Oral Investigations · doi:10.1007/s00784-016-1780-9 · Cited by 38
CC3/TIP30 regulates metabolic adaptation of tumor cells to glucose limitation
Chen, V., & Shtivelman, E. (2010) · Cell Cycle · doi:10.4161/cc.9.24.14230 · Cited by 36
Glutaminase inhibition in multiple myeloma induces apoptosisviaMYC degradation
Effenberger, M., Bommert, K. S., Kunz, V., Kruk, J., Leich, E., Rudelius, M., Bargou, R. C., & Bommert, K. (2017) · Oncotarget · doi:10.18632/oncotarget.20691 · Cited by 38
The real face of HIF1α in the tumor process
Kappler, M., Taubert, H. W., Schubert, J., Vordermark, D., & Eckert, A. W. (2012) · Cell Cycle · doi:10.4161/cc.21854 · Cited by 38
Cheng, Y., Diao, D., Zhang, H., Guo, Q., Wu, X., Song, Y., & Dang, C. (2013) · Biomedical Reports · doi:10.3892/br.2013.211 · Cited by 36
Self-citationReplication of the Shrimp Virus WSSV Depends on Glutamate-Driven Anaplerosis
Li, C.-Y., Wang, Y.-J., Huang, S.-W., Cheng, C.-S., & Wang, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146902 · Cited by 37
Downregulation of CENPF Remodels Prostate Cancer Cells and Alters Cellular Metabolism
Shahid, M., Kim, M., Lee, M. Y., Yeon, A., You, S., Kim, H. L., & Kim, J. (2019) · PROTEOMICS · doi:10.1002/pmic.201900038 · Cited by 36
Pidoux, G., Gerbaud, P., Guibourdenche, J., Thérond, P., Ferreira, F., Simasotchi, C., Evain‐Brion, D., & Gil, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133506 · Cited by 36
Metabolic Imaging to Assess Treatment Response to Cytotoxic and Cytostatic Agents
Serkova, N. J., & Eckhardt, S. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00152 · Cited by 36
Personalizing Nutrition Strategies: Bridging Research and Public Health
Clemente‐Suárez, V. J., Peris-Ramos, H. C., Redondo-Flórez, L., Beltrán-Velasco, A. I., Martín-Rodríguez, A., David-Fernandez, S., Sepulveda, R. A. Y., & Tornero-Aguilera, J. F. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14030305 · Cited by 38
2-Substituted Nγ-glutamylanilides as novel probes of ASCT2 with improved potency
Schulte, M. I., Dawson, E. S., Saleh, S. A., Cuthbertson, M. L., & Manning, H. C. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.10.098 · Cited by 35
Nair, V. S., Keu, K. V., Luttgen, M. S., Kolatkar, A. R., Vasanawala, M., Kuschner, W. G., Bethel, K. J., Iagaru, A. H., Hoh, C. K., Shrager, J. B., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067733 · Cited by 35
Role of LncRNAs in regulating cancer amino acid metabolism
Guo, Y., Lv, B., Liu, R., Dai, Z., Zhang, F., Liang, Y., Yu, B., Zeng, D., Lv, X., & Zhang, Z. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01926-8 · Cited by 35
Urayama, S. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i6.1707 · Cited by 36
Nuclear morphometry, nucleomics and prostate cancer progression
Veltri, R. W., Christudass, C. S., & Isharwal, S. (2012) · Asian Journal of Andrology · doi:10.1038/aja.2011.148 · Cited by 34
Jiang, X., Chang, H., & Zhou, Y. G. (2015) · Protein Expression and Purification · doi:10.1016/j.pep.2015.05.010 · Cited by 33
The metabolomic signature of hematologic malignancies
Allegra, A., Innao, V., Gerace, D. G., Bianco, O., & Musolino, C. (2016) · Leukemia Research · doi:10.1016/j.leukres.2016.08.002 · Cited by 32
Haga, H., Matsuo, K., Yabuki, Y., Zhang, C., Han, F., & Fukunaga, K. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104492 · Cited by 33
D’Alessandro, G., Quaglio, D., Monaco, L., Lauro, C., Ghirga, F., Ingallina, C., De Martino, M., Fucile, S., Porzia, A., Di Castro, M. A., et al. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0421-8 · Cited by 32
Metadata
- Authors
- Dang, C. V.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Dang, Chi V.
- ORCID
- Dang, Chi V.
- Venue
- Cancer Research
- Published
- 2010-01-31
- Volume
- 70
- Issue
- 3
- Pages
- 859-862
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- PMC
- PMC2818441
- OpenAlex
- W2070371419
- Cited by
- 379
- References
- 20
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 11 · 2023: 15 · 2022: 14 · 2021: 17 · 2020: 22 · 2019: 18 · 2018: 26 · 2017: 24 · 2016: 35 · 2015: 33 · 2014: 36 · 2013: 36 · 2012: 41
- FWCI
- 12.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA 57341, R01CA057341, CA 51497, R37CA051497, R01CA051497)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- Warburg effect, MYC oncogene, glutamine metabolism, glutamine catabolism, microRNA repression, miR-23a, miR-23b, cancer metabolism, tumor hypoxia, tumor stroma
- MeSH terms
- Animals, Citric Acid Cycle, Glucose, Glutamine, Humans, Mitochondria, Models, Biological, Neoplasms, Gene Expression Regulation, Neoplastic, Proto-Oncogene Proteins c-myc, MicroRNAs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review